Developmental of healthcare is not charity, says Dr Saripalli
A leading global healthcare investment fund has offered US$70 million to Pinnacle Blooms Network, the flagship pediatric-therapy enterprise of Bharath Healthcare Laboratories Pvt Ltd for technology acceleration and domestic as well as regional expansion covering Southeast Asia and GCC.
The proposed funding is structured in two phases. Phase 1 comprises $70 million for rapid domestic expansion and technology acceleration. Phase 2 envisions a follow-on tranche as Pinnacle expands into Southeast Asia and the GCC. Capital deployment would fund expansion from 70+ to 300 centres within 24 months, R&D acceleration for home-based TherapeuticAI® applications, large-scale manufacturing of TherapySphere™ sensory rooms, and regulatory submissions for international market access.
The proposed two-tranche Series A investment—advised by Yukon Capital—would represent one of the largest early-stage financings in child-development infrastructure anywhere in Asia. The offer comes as Pinnacle evaluates strong interest from multiple global institutional investors seeking exposure to the fast-emerging developmental health sector https://www.bseindia.com/.
Pinnacle operates more than 70 multi-disciplinary therapy centres across India – and has delivered over 20 million one-to-one therapy sessions to date. The company’s proprietary Pinnacle Child Development Operating System (GPT-OS®) is a multi-patent-filed digital-therapeutic platform that measures, forecasts, and personalises every dimension of a child’s developmental journey across speech, motor, cognitive, and behavioural domains.
The GPT-OS® architecture integrates modules including Diagnosis, Prognosis, TherapeuticAI®, AbilityScore®, Seven Readiness Indexes®, and TherapySphere™—multi-sensory therapeutic environments designed to accelerate neurological development in children with autism, speech delays, ADHD, and related conditions.
Aneesh Madhav, Chief Executive Officer, Yukon Capital, said on 29 Dec, “We’ve advised on healthcare transactions across four continents, and Pinnacle is unlike anything we’ve seen. They’ve solved the fundamental problem in developmental health—how do you make therapy measurable, scalable, and accessible without losing the human element? GPT-OS® isn’t a feature; it’s infrastructure.
“This is the operating system layer for childhood development globally. The question isn’t whether this category will attract institutional capital—it’s who will move decisively enough to lead it https://www.nseindia.com/.”
Dr. Koti Reddy Saripalli, Founder & Chairman, Bharath Healthcare Laboratories, shared, “The world has finally recognized that developmental health is not charity; it’s essential infrastructure. We’re not raising capital to grow. We’re raising capital to ensure that every child on earth who needs measurable therapy can access it—starting from their own home.
“Fourteen years ago, we began with one conviction: no parent should ever be told there’s nothing more that can be done for their child. Today, we’ve delivered 20 million therapy sessions, and every single one generated data that makes the next session smarter. What we’ve built isn’t a clinic chain—it’s a learning system that compounds.”
Dr. Sreeja Reddy Saripalli, Co-Founder & Clinical Director, Bharath Healthcare Laboratories, elaborated, “For too long, parents have been given hope without evidence. They were told ‘trust the process’ but never shown the progress. We changed that. When a mother watches her dashboard shift from red to yellow to green—when she sees her child’s AbilityScore® climb week after week—that’s not just data. That’s her child’s future becoming visible. GPT-OS® has given families something therapy never could before: clarity. And clarity, in the life of a special-needs parent, is everything https://www.meity.gov.in/.”
Pinnacle is targeting expansion from 70+ therapy centres today to 300+ within 24 months and 600+ within four years, with projected annual revenue scaling from Rs.160+ crore to Rs.6,000 crore. Geographic presence will extend beyond India into Southeast Asia and the GCC, while the company’s home therapy reach—currently in pilot—will expand to a pan-India OTT platform enabling parent-led intervention at scale.
International pilots are under discussion in Indonesia, Vietnam, the Philippines, and the GCC, with the company’s Everyday Therapy Programmes™ planned for regional-language deployment via OTT modules and parent-as-co-therapist training.
The transaction interest values the broader Bharath Healthcare group in the high-triple-digit-million-dollar range—reflecting both its physical infrastructure and the software multiples typical of high-growth health-tech platforms https://sbi.com.in/.
India’s developmental health sector remains significantly underserved, with an estimated 3+ million children with autism and tens of millions more requiring speech, occupational, and behavioural therapy. The global paediatric therapy market is projected to exceed US$50 billion by 2030, with AI-enabled platforms emerging as the fastest-growing segment.
Yukon Capital is a healthcare-focused advisory and investment firm guiding growth-stage innovators across life sciences, medical technology, and digital therapeutics. The firm provides strategic, regulatory, and capital-raising expertise to companies advancing global health outcomes. Fiinews.com
